Anti-Microbialvior BioteQ Co (ROCO:6864) ROCE % : -45.63% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Anti-Microbialvior BioteQ Co's annualized ROCE % for the quarter that ended in Dec. 2023 was -45.63%.

Anti-Microbialvior BioteQ Co ROCE % Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co ROCE % Chart

Anti-Microbialvior BioteQ Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-11.65

-16.27

-15.33

-20.41

-38.52

Anti-Microbialvior BioteQ Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial				-17.91	-15.23	-25.37	-31.29	-45.63

Anti-Microbialvior BioteQ Co ROCE % Calculation

Anti-Microbialvior BioteQ Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-56.749	/	( ( (181.964 - 8.385)	+	(128.047 - 6.994) )	/ 2 )
	=	-56.749	/	( (173.579	+	121.053)	/ 2 )
	=	-56.749	/	147.316
	=	-38.52 %

Anti-Microbialvior BioteQ Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-62.45	/	( ( (158.279 - 5.618)	+	(128.047 - 6.994) )	/ 2 )
	=	-62.45	/	( ( 152.661	+	121.053 )	/ 2 )
	=	-62.45	/	136.857
	=	-45.63 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Anti-Microbialvior BioteQ Co (ROCO:6864) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Anti-Microbialvior BioteQ Co ROCE % Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Anti-Microbialvior BioteQ Co (ROCO:6864) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sec.1, Huandong Road, 1 Floor, No. 2, Ln. 31, Xinshi District, Tainan, TWN, 741

Website

https://www.ams-bioteq.com

Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co (ROCO:6864) Headlines

No Headlines